FDA Import Refusal SCS-9591841-7/11/1 — BROSCARGO INT'L CO., LTD.
The FDA refused shipment SCS-9591841-7/11/1 from BROSCARGO INT'L CO., LTD. (South Korea) on May 13, 2025. The refused product falls under Drugs and Biologics — TAMOXIFEN CITRATE (ANTI-ESTROGEN). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- May 13, 2025
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 61UCY05 TAMOXIFEN CITRATE (ANTI-ESTROGEN)
- Charges
- 118,75